Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galena Biopharma Inc (NASDAQ:GALE)

1.38
Delayed Data
As of Apr 29
 -0.05 / -3.50%
Today’s Change
0.59
Today|||52-Week Range
2.39
-6.12%
Year-to-Date
No recent news for Galena Biopharma Inc.

Today’s Trading

Previous close1.43
Today’s open1.46
Day’s range1.38 - 1.46
Volume1,320,625
Average volume (3 months)2,058,142
Market cap$250.8M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-23.32%
Earnings growth (this year)+39.51%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book16.53

Competitors

 Today’s
change
Today’s
% change
CRVSCorvus Pharmaceutica...-0.54-4.23%
ARLZAralez Pharmaceutica...-0.19-4.63%
ZGNXZogenix Inc-0.38-3.57%
SRNESorrento Therapeutic...-0.04-0.58%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 11, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$59.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
San Ramon, California

Forecasts

Partner Offers

Search for Jobs